Overview
GLP-1 Companion is a feature suite within MyNetDiary Premium designed for people taking GLP-1 weight loss medications, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Launched on May 5, 2026, GLP-1 Companion brings together injection reminders, protein-focused tracking, digestive symptom logging, and dietitian-designed meal plans inside the same app that already serves 31 million MyNetDiary users.
This press kit provides product imagery, screenshots, and supporting materials for editorial coverage. All assets are available for use by the press in connection with stories about MyNetDiary, GLP-1 Companion, or related coverage of nutrition tracking technology. Please credit MyNetDiary in image captions.
Product Screenshots
iOS Dashboard
The MyNetDiary Dashboard on iPhone, with protein elevated as the primary nutrient. The Ozempic medication card sits at the top, and Day Events show "Moderate Bloating" and "Low appetite" logged below. International expert consensus published in Obesity Pillars (Sievenpiper et al., 2025) recommends prioritizing protein during rapid weight loss to preserve muscle mass — for most adults, roughly 80–120 grams per day.
Android Dashboard
The same MyNetDiary Dashboard on Android, illustrating full feature parity at launch. GLP-1 Companion is available on iOS and Android with no platform-specific feature gaps.
GLP-1 Companion
The GLP-1 Companion screen shows weekly GLP-1 medication doses, weight trend, Day Events frequency, and Daily Notes consistency in a single integrated view, making it easier for patients to share progress with their healthcare team.
Medication Tracker
The GLP-1 medication tracker logs injection type, dose, and timing, with customizable reminders. Medication history sits alongside food, weight, and symptom data — no separate medication app needed.
Day Event and Symptom Tracker
Users log digestive symptoms (nausea, bloating, constipation), focus and energy states, hunger and fullness levels, and other GLP-1 side effects on both iOS and Android. Pattern-spotting across symptoms, food choices, and dosage timing is one of the central clinical use cases for GLP-1 Companion.
GLP-1 Diet
The GLP-1 Diet plan inside MyNetDiary, authored by RDN Amy Brownstein. The plan emphasizes nutrient-dense foods to stabilize blood sugar, curb appetite, and support steady weight loss while preserving muscle mass.
GLP-1 Menus
A sample GLP-1 Premium Menu providing at least 80 grams of protein per day, balanced with healthy carbs, with high-fat and spicy foods limited. Two dietitian-designed daily menus are available in GLP-1 Companion, each with seven days of meal ideas.
GLP-1 Recipes
The curated GLP-1 recipe collection inside MyNetDiary's Premium Recipes & Meals library, with each recipe labeled by protein content per serving and built around protein density, digestibility, and smaller portions.
Logos and Brand Marks
MyNetDiary App Icon
The MyNetDiary brand logos for use in editorial layouts.
Headshots and Bios
Sergey Oreshko, CEO and Co-Founder
Sergey Oreshko founded MyNetDiary in 2005. He oversees product strategy, competitive positioning, and platform direction. Available for interviews on founder perspective, product strategy, competitive positioning, and nutrition tracking technology.
Sue Heikkinen, MS, RDN, CDCES, BC-ADM, ACE-PT, Lead Dietitian and Clinical Reviewer
Sue Heikkinen leads clinical review at MyNetDiary. She is a Registered Dietitian Nutritionist, Certified Diabetes Care and Education Specialist, Board-Certified Advanced Diabetes Management specialist, and ACE-Certified Personal Trainer. Available for interviews on clinical aspects of GLP-1 nutrition, dietitian perspective, diabetes management, and behavior change.
Fact Sheet
- GLP-1 Companion launched May 5, 2026
- Available in MyNetDiary Premium on iOS and Android, with full feature parity at launch
- Pricing: $9.99 per month or $59.99 per year; free tier available, ad-free
- Built on a staff-verified database of 2M+ foods tracking 108 nutrients
- Supports semaglutide and tirzepatide medications (Ozempic, Wegovy, Mounjaro, Zepbound)
- Approximately 1 in 8 U.S. adults are on GLP-1 medications (KFF Health Tracking Poll, November 2025)
- Up to 40% of weight lost on GLP-1 medications can come from lean body mass; protein and strength training help preserve muscle
Press Release
MyNetDiary Launches GLP-1 Companion for Ozempic, Wegovy, and Mounjaro Users
May 5, 2026 — Boca Raton, FL
Download press release (PDF) →
Download press release (DOCX) →
Media Contact
For press inquiries, interview requests, or additional materials:
Alina Voronchak, PR & Outreach
MyNetDiary Inc.
press@mynetdiary.com
621 NW 53rd St., Suite 240
Boca Raton, FL 33487
Usage Rights
Members of the press are welcome to use these assets for editorial coverage of MyNetDiary, GLP-1 Companion, and related stories. Please credit MyNetDiary in image captions. For commercial, partnership, or non-editorial use, please contact us before publication.